Supplementary material - Effect of drug-to-lipid ratio on nanodisc-based tenofovir drug delivery to the brain for HIV-1 infection

This work was supported by research support in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract no. HHSN272201400006I and NIH grants #1R15NS108815-01 and #1R01AI147731-01A1. Additionally, internal funding was provided by the University of Texas Rio Grande Valley. A US patent application has been filed on this work (PCT/US21/46708).